# Blue Water Vaccines

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/blue-water-vaccines

- Industry: Biotechnology
- Headquarters: Cincinnati, US
- Website: www.bluewatervaccines.com
- Total disclosed funding: $7M
- Latest round: Seed (Jul 1, 2019)
- Investors on record: 1

## About

Blue Water Vaccines, Inc. is a biotechnology company focused on developing innovative vaccine therapies, particularly targeting infectious diseases.Founded in 2018 and headquartered in Cincinnati, US, Blue Water Vaccines, Inc. specializes in vaccine development. The company has engaged in five deals and has shifted strategies over time to focus more on innovative vaccine solutions. It raised USD 19.99 million in an IPO in February 2022, followed by a Private Placement/Follow on round that secured USD 9.38 million on August 11, 2022. The company’s CEO is Joseph Hernandez.Blue Water Vaccines, Inc. is dedicated to creating vaccines aimed at preventing infectious diseases, employing advanced research methodologies. The firm's current pipeline includes novel vaccine candidates, with a focus on addressing unmet medical needs. The company aims to improve public health outcomes through its innovative approaches to vaccine development.For the year 2023, Blue Water Vaccines, Inc. reported a revenue of USD 58,465, while its EBITDA was recorded at USD -35,363,222, indicating a loss.Blue Water Vaccines, Inc. plans to utilize its most recent funding of USD 9.38 million towards additional preclinical studies, progressing to a Phase 1 trial targeted for 2020. The company aims to expand its research efforts into new vaccine technologies and explore market opportunities in various regions, including North America and Europe, by 2024. This strategic funding will support the ongoing development of their vaccine candidates as they move toward clinical trials.

## Funding rounds

- Seed, Jul 1, 2019, $7M — CincyTech

## Investors

- CincyTech (https://capitalatlas.ai/funds/cincytech) — Seed